Literature DB >> 3119122

Prognosis in adult asthma: a national study.

H L Markowe1, C J Bulpitt, M J Shipley, G Rose, D L Crombie, D M Fleming.   

Abstract

Although one million people consult their general practitioners for asthma each year, data on the prognosis of this disease are scarce, particularly in adults. Mortality was studied among 2547 adult asthmatics attending a national sample of 60 general practices between 1970 and 1976; they were compared with a matched group of non-asthmatic patients. Mortality from all causes was significantly raised in the asthmatic cohort (189 deaths v 112 among controls; relative risk 1.61, 95% confidence interval 1.3 to 2.0), especially in women (92 v 42 deaths; relative risk 2.2 (1.5 to 3.1)), and in the oldest age group (55-59 years). In both sexes the predominant cause of excess mortality was respiratory disease, particularly asthma (25 v 0 deaths) and chronic obstructive airways disease (37 v 4 deaths; relative risk 8.8 (2.8 to 23)). Overall, 94% of the asthmatic cohort survived the mean follow up period of eight years compared with 96% of the controls. In contrast to previous findings, the risk of death due to malignant neoplasms was not significantly reduced overall (34 v 36 deaths), though the risk was significantly reduced among those aged under 45 years (2 v 10 deaths; relative risk 0.2 (0.02 to 0.9)) and there was a significant trend of lowering of relative risk with younger age (p less than 0.01).

Entities:  

Mesh:

Year:  1987        PMID: 3119122      PMCID: PMC1248001          DOI: 10.1136/bmj.295.6604.949

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

1.  Asthma: a study in prognosis of 1,000 patients.

Authors:  A G OGILVIE
Journal:  Thorax       Date:  1962-09       Impact factor: 9.139

2.  Controlled investigation of deaths from asthma in hospitals in the North East Thames region.

Authors:  J Eason; H L Markowe
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

3.  Mortality from respiratory disease at follow-up of patients with asthma.

Authors:  M Alderson; R M Loy
Journal:  Br J Dis Chest       Date:  1977-07

4.  Allergy and cancer.

Authors:  P D Meers
Journal:  Lancet       Date:  1973-04-21       Impact factor: 79.321

5.  Asthma mortality in England and Wales.

Authors: 
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

6.  Asthma and subsequent mortality in World War II veterans.

Authors:  C D Robinette; J F Fraumeni
Journal:  J Chronic Dis       Date:  1978

7.  The analysis of mortality by the subject-years method.

Authors:  G Berry
Journal:  Biometrics       Date:  1983-03       Impact factor: 2.571

8.  Mortality from asthma: a new epidemic in New Zealand.

Authors:  R T Jackson; R Beaglehole; H H Rea; D C Sutherland
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18

9.  Cigarette smoking in asthma.

Authors:  T W Higenbottam; C Feyeraband; T J Clark
Journal:  Br J Dis Chest       Date:  1980-07

10.  A comparison of cancer occurrence in allergic and nonallergic populations.

Authors:  W F Hughes; R L Raitz
Journal:  Ann Allergy       Date:  1979-09
View more
  19 in total

1.  Mortality of elderly subjects with self-reported asthma in a French cohort, 1991-1996.

Authors:  C Dantzer; J F Tessier; C Nejjari; P Barberger-Gateau; J F Dartigues
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Preferential prescribing of oral corticosteroids in Irish male asthmatic children.

Authors:  D Williams; A Kelly; J Feely
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

Review 3.  Low dose inhaled corticosteroids and the prevention of death from asthma.

Authors:  J C Kips; R A Pauwels
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

4.  Mortality of adults with asthma: a prospective cohort study.

Authors:  E Huovinen; J Kaprio; E Vesterinen; M Koskenvuo
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

5.  Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany.

Authors:  P K Schädlich; J G Brecht
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

6.  Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes.

Authors:  P Lange; J Nyboe; M Appleyard; G Jensen; P Schnohr
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

7.  Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.

Authors:  H F Guite; R Dundas; P G Burney
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

8.  Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium.

Authors:  Albert Rosenberger; Heike Bickeböller; Valerie McCormack; Darren R Brenner; Eric J Duell; Anne Tjønneland; Soren Friis; Joshua E Muscat; Ping Yang; H-Erich Wichmann; Joachim Heinrich; Neonila Szeszenia-Dabrowska; Jolanta Lissowska; David Zaridze; Peter Rudnai; Eleonora Fabianova; Vladimir Janout; Vladimir Bencko; Paul Brennan; Dana Mates; Ann G Schwartz; Michele L Cote; Zuo-Feng Zhang; Hal Morgenstern; Sam S Oh; John K Field; Olaide Raji; John R McLaughlin; John Wiencke; Loic LeMarchand; Monica Neri; Stefano Bonassi; Angeline S Andrew; Qing Lan; Wei Hu; Irene Orlow; Bernard J Park; Paolo Boffetta; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2011-12-22       Impact factor: 4.944

9.  Cross-sectional observations on the natural history of asthma.

Authors:  R G Neville; C McCowan; G Hoskins; G Thomas
Journal:  Br J Gen Pract       Date:  2001-05       Impact factor: 5.386

10.  Prevalence and diagnosis of chronic respiratory symptoms in adults.

Authors:  P Littlejohns; S Ebrahim; R Anderson
Journal:  BMJ       Date:  1989-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.